Cargando…
Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy
STUDY OBJECTIVES: To follow the temporal changes of cerebrospinal fluid (CSF) biomarker levels in narcoleptic patients with unexpected hypocretin level at referral. METHODS: From 2007 to 2015, 170 human leukocyte antigen (HLA) DQB1*06:02-positive patients with primary narcolepsy and definite (n = 15...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806580/ https://www.ncbi.nlm.nih.gov/pubmed/28364477 http://dx.doi.org/10.1093/sleep/zsw010 |
_version_ | 1783299153902698496 |
---|---|
author | Lopez, Régis Barateau, Lucie Evangelista, Elisa Chenini, Sofiene Robert, Philippe Jaussent, Isabelle Dauvilliers, Yves |
author_facet | Lopez, Régis Barateau, Lucie Evangelista, Elisa Chenini, Sofiene Robert, Philippe Jaussent, Isabelle Dauvilliers, Yves |
author_sort | Lopez, Régis |
collection | PubMed |
description | STUDY OBJECTIVES: To follow the temporal changes of cerebrospinal fluid (CSF) biomarker levels in narcoleptic patients with unexpected hypocretin level at referral. METHODS: From 2007 to 2015, 170 human leukocyte antigen (HLA) DQB1*06:02-positive patients with primary narcolepsy and definite (n = 155, 95 males, 60 females, 36 children) or atypical cataplexy (n = 15, 4 males, 3 children) were referred to our center. Cerebrospinal hypocretin deficiency was found in 95.5% and 20% of patients with definitive and atypical cataplexy, respectively. CSF hypocretin-1 (n = 6) and histamine/tele-methylhistamine (n = 5) levels were assessed twice (median interval: 14.4 months) in four patients with definite and in two with atypical cataplexy and hypocretin level greater than 100 pg/mL at baseline. RESULTS: CSF hypocretin levels decreased from normal/intermediate to undetectable levels in three of the four patients with definite cataplexy and remained stable in the other (>250 pg/mL). Hypocretin level decreased from 106 to 27 pg/mL in one patient with atypical cataplexy, and remained stable in the other (101 and 106 pg/mL). CSF histamine and tele-methylhistamine levels remained stable, but for one patient showing increased frequency of cataplexy and a strong decrease (−72.5%) of tele-methylhistamine levels several years after disease onset. No significant association was found between relative or absolute change in hypocretin level and demographic/clinical features. CONCLUSIONS: These findings show that in few patients with narcolepsy with cataplexy, symptoms and CSF marker levels can change over time. In these rare patients with cataplexy without baseline hypocretin deficiency, CSF markers should be monitored over time with potential for immune therapies in early stages to try limiting hypocretin neuron loss. |
format | Online Article Text |
id | pubmed-5806580 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-58065802018-02-23 Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy Lopez, Régis Barateau, Lucie Evangelista, Elisa Chenini, Sofiene Robert, Philippe Jaussent, Isabelle Dauvilliers, Yves Sleep Original Article STUDY OBJECTIVES: To follow the temporal changes of cerebrospinal fluid (CSF) biomarker levels in narcoleptic patients with unexpected hypocretin level at referral. METHODS: From 2007 to 2015, 170 human leukocyte antigen (HLA) DQB1*06:02-positive patients with primary narcolepsy and definite (n = 155, 95 males, 60 females, 36 children) or atypical cataplexy (n = 15, 4 males, 3 children) were referred to our center. Cerebrospinal hypocretin deficiency was found in 95.5% and 20% of patients with definitive and atypical cataplexy, respectively. CSF hypocretin-1 (n = 6) and histamine/tele-methylhistamine (n = 5) levels were assessed twice (median interval: 14.4 months) in four patients with definite and in two with atypical cataplexy and hypocretin level greater than 100 pg/mL at baseline. RESULTS: CSF hypocretin levels decreased from normal/intermediate to undetectable levels in three of the four patients with definite cataplexy and remained stable in the other (>250 pg/mL). Hypocretin level decreased from 106 to 27 pg/mL in one patient with atypical cataplexy, and remained stable in the other (101 and 106 pg/mL). CSF histamine and tele-methylhistamine levels remained stable, but for one patient showing increased frequency of cataplexy and a strong decrease (−72.5%) of tele-methylhistamine levels several years after disease onset. No significant association was found between relative or absolute change in hypocretin level and demographic/clinical features. CONCLUSIONS: These findings show that in few patients with narcolepsy with cataplexy, symptoms and CSF marker levels can change over time. In these rare patients with cataplexy without baseline hypocretin deficiency, CSF markers should be monitored over time with potential for immune therapies in early stages to try limiting hypocretin neuron loss. Oxford University Press 2017-02-09 /pmc/articles/PMC5806580/ /pubmed/28364477 http://dx.doi.org/10.1093/sleep/zsw010 Text en © Sleep Research Society 2017. Published by Oxford University Press [on behalf of the Sleep Research Society]. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Lopez, Régis Barateau, Lucie Evangelista, Elisa Chenini, Sofiene Robert, Philippe Jaussent, Isabelle Dauvilliers, Yves Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy |
title | Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and
Histamine in Narcolepsy |
title_full | Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and
Histamine in Narcolepsy |
title_fullStr | Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and
Histamine in Narcolepsy |
title_full_unstemmed | Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and
Histamine in Narcolepsy |
title_short | Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and
Histamine in Narcolepsy |
title_sort | temporal changes in the cerebrospinal fluid level of hypocretin-1 and
histamine in narcolepsy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806580/ https://www.ncbi.nlm.nih.gov/pubmed/28364477 http://dx.doi.org/10.1093/sleep/zsw010 |
work_keys_str_mv | AT lopezregis temporalchangesinthecerebrospinalfluidlevelofhypocretin1andhistamineinnarcolepsy AT barateaulucie temporalchangesinthecerebrospinalfluidlevelofhypocretin1andhistamineinnarcolepsy AT evangelistaelisa temporalchangesinthecerebrospinalfluidlevelofhypocretin1andhistamineinnarcolepsy AT cheninisofiene temporalchangesinthecerebrospinalfluidlevelofhypocretin1andhistamineinnarcolepsy AT robertphilippe temporalchangesinthecerebrospinalfluidlevelofhypocretin1andhistamineinnarcolepsy AT jaussentisabelle temporalchangesinthecerebrospinalfluidlevelofhypocretin1andhistamineinnarcolepsy AT dauvilliersyves temporalchangesinthecerebrospinalfluidlevelofhypocretin1andhistamineinnarcolepsy |